Emerging causes of morbidity and mortality in organ transplant patients

Michael Torbenson

Research output: Contribution to journalArticle

Abstract

PURPOSE OF REVIEW: As short-term allograft and patient survival has improved following solid organ transplantation, medium and long-term causes of morbidity and mortality have come to the forefront of patient care. RECENT FINDINGS: The metabolic syndrome has relatively recently been defined and is now being applied to studies of posttransplant morbidity and mortality. The metabolic syndrome, and its individual risk factors such as obesity and diabetes mellitus, are highly prevalent in all solid organ transplant populations and negatively impact allograft and patient survival. Even when the metabolic syndrome is not present prior to transplantation, weight gain and the metabolic syndrome can develop following transplantation with negative outcomes. A second growing concern following transplantation is the development of late malignancies. The strongest risk factors include pretransplant conditions such as tobacco use, excess alcohol use, and idiopathic inflammatory bowel disease. In select populations, continued tobacco use following transplantation is disappointingly high. De-novo carcinomas in renal and hepatic allografts are also likely to be a growing concern. SUMMARY: The metabolic syndrome and malignancies are important causes of morbidity and mortality following solid organ transplantation. Continued work is needed to fully understand the magnitude of the risks as well as methods of intervention.

Original languageEnglish (US)
Pages (from-to)304-310
Number of pages7
JournalCurrent Opinion in Organ Transplantation
Volume11
Issue number3
DOIs
StatePublished - Jun 2006

Fingerprint

Morbidity
Transplants
Transplantation
Mortality
Allografts
Tobacco Use
Organ Transplantation
Survival
Inflammatory Bowel Diseases
Population
Weight Gain
Neoplasms
Patient Care
Diabetes Mellitus
Obesity
Alcohols
Carcinoma
Kidney
Liver

Keywords

  • De-novo carcinoma
  • Diabetes mellitus
  • Metabolic syndrome
  • Morbidity
  • Mortality

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this

Emerging causes of morbidity and mortality in organ transplant patients. / Torbenson, Michael.

In: Current Opinion in Organ Transplantation, Vol. 11, No. 3, 06.2006, p. 304-310.

Research output: Contribution to journalArticle

@article{2ee2b9cc5328492cbc6679c1d035c96d,
title = "Emerging causes of morbidity and mortality in organ transplant patients",
abstract = "PURPOSE OF REVIEW: As short-term allograft and patient survival has improved following solid organ transplantation, medium and long-term causes of morbidity and mortality have come to the forefront of patient care. RECENT FINDINGS: The metabolic syndrome has relatively recently been defined and is now being applied to studies of posttransplant morbidity and mortality. The metabolic syndrome, and its individual risk factors such as obesity and diabetes mellitus, are highly prevalent in all solid organ transplant populations and negatively impact allograft and patient survival. Even when the metabolic syndrome is not present prior to transplantation, weight gain and the metabolic syndrome can develop following transplantation with negative outcomes. A second growing concern following transplantation is the development of late malignancies. The strongest risk factors include pretransplant conditions such as tobacco use, excess alcohol use, and idiopathic inflammatory bowel disease. In select populations, continued tobacco use following transplantation is disappointingly high. De-novo carcinomas in renal and hepatic allografts are also likely to be a growing concern. SUMMARY: The metabolic syndrome and malignancies are important causes of morbidity and mortality following solid organ transplantation. Continued work is needed to fully understand the magnitude of the risks as well as methods of intervention.",
keywords = "De-novo carcinoma, Diabetes mellitus, Metabolic syndrome, Morbidity, Mortality",
author = "Michael Torbenson",
year = "2006",
month = "6",
doi = "10.1097/01.mot.0000227850.44699.8d",
language = "English (US)",
volume = "11",
pages = "304--310",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Emerging causes of morbidity and mortality in organ transplant patients

AU - Torbenson, Michael

PY - 2006/6

Y1 - 2006/6

N2 - PURPOSE OF REVIEW: As short-term allograft and patient survival has improved following solid organ transplantation, medium and long-term causes of morbidity and mortality have come to the forefront of patient care. RECENT FINDINGS: The metabolic syndrome has relatively recently been defined and is now being applied to studies of posttransplant morbidity and mortality. The metabolic syndrome, and its individual risk factors such as obesity and diabetes mellitus, are highly prevalent in all solid organ transplant populations and negatively impact allograft and patient survival. Even when the metabolic syndrome is not present prior to transplantation, weight gain and the metabolic syndrome can develop following transplantation with negative outcomes. A second growing concern following transplantation is the development of late malignancies. The strongest risk factors include pretransplant conditions such as tobacco use, excess alcohol use, and idiopathic inflammatory bowel disease. In select populations, continued tobacco use following transplantation is disappointingly high. De-novo carcinomas in renal and hepatic allografts are also likely to be a growing concern. SUMMARY: The metabolic syndrome and malignancies are important causes of morbidity and mortality following solid organ transplantation. Continued work is needed to fully understand the magnitude of the risks as well as methods of intervention.

AB - PURPOSE OF REVIEW: As short-term allograft and patient survival has improved following solid organ transplantation, medium and long-term causes of morbidity and mortality have come to the forefront of patient care. RECENT FINDINGS: The metabolic syndrome has relatively recently been defined and is now being applied to studies of posttransplant morbidity and mortality. The metabolic syndrome, and its individual risk factors such as obesity and diabetes mellitus, are highly prevalent in all solid organ transplant populations and negatively impact allograft and patient survival. Even when the metabolic syndrome is not present prior to transplantation, weight gain and the metabolic syndrome can develop following transplantation with negative outcomes. A second growing concern following transplantation is the development of late malignancies. The strongest risk factors include pretransplant conditions such as tobacco use, excess alcohol use, and idiopathic inflammatory bowel disease. In select populations, continued tobacco use following transplantation is disappointingly high. De-novo carcinomas in renal and hepatic allografts are also likely to be a growing concern. SUMMARY: The metabolic syndrome and malignancies are important causes of morbidity and mortality following solid organ transplantation. Continued work is needed to fully understand the magnitude of the risks as well as methods of intervention.

KW - De-novo carcinoma

KW - Diabetes mellitus

KW - Metabolic syndrome

KW - Morbidity

KW - Mortality

UR - http://www.scopus.com/inward/record.url?scp=33744465526&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33744465526&partnerID=8YFLogxK

U2 - 10.1097/01.mot.0000227850.44699.8d

DO - 10.1097/01.mot.0000227850.44699.8d

M3 - Article

VL - 11

SP - 304

EP - 310

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 3

ER -